arecoline has been researched along with fluoxetine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Cherkin, A; Flood, JF; Smith, GE | 1 |
Chau, D; Hoebel, BG; Kosloff, RA; Rada, PV | 1 |
3 other study(ies) available for arecoline and fluoxetine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Memory enhancement in mice: role of drug dose and training-testing interval.
Topics: Adrenocorticotropic Hormone; Animals; Arecoline; Avoidance Learning; Clonidine; Dose-Response Relationship, Drug; Fluoxetine; Male; Memory; Memory, Short-Term; Mice; Naloxone; Peptide Fragments; Piribedil; Time Factors | 1988 |
Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Animals; Arecoline; Depression; Female; Fluoxetine; Microinjections; Motor Activity; Nucleus Accumbens; Pirenzepine; Posture; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Scopolamine; Swimming | 1999 |